Interestingly, the enrichment of MBD3 or the 5mC-binding protein MBD2 indicates entirely opposite outcomes in the glioma survival even though they share a >70% similarity in protein sequences (Figures S15-S16). Here, MBD2 is linked to central nervous system cancer.